Viewing StudyNCT00440765



Ignite Creation Date: 2024-05-05 @ 5:22 PM
Last Modification Date: 2024-10-26 @ 9:31 AM
Study NCT ID: NCT00440765
Status: COMPLETED
Last Update Posted: 2014-01-14
First Post: 2007-02-26

Brief Title: VALEO A Post Authorization Study Designed to Learn More About the Safety and Effectiveness of the Use of Bortezomib in the Netherlands
Sponsor: Janssen-Cilag BV
Organization: Janssen-Cilag BV

Conditions & Keywords Data

Conditions:
Name
Hematological Neoplasms
Multiple Myeloma
Keywords:
Name View
proteasome inhibitor View
Multiple Myeloma View
hematological Neoplasms View
chemotherapy View
efficacy View
safety View
bortezomib View